Search results for " hydrocephalus"

showing 10 items of 14 documents

Letter to the Editor. Idiopathic normal pressure hydrocephalus: is 1-year follow-up enough?

2022

idiopathic normal pressure hydrocephalus adultGeneral MedicineJournal of neurosurgery
researchProduct

Intraoperative monitoring of cerebral blood flow during ventricular shunting in hydrocephalic pediatric patients.

1995

Several studies have demonstrated lowered cerebral blood flow (CBF) in patients with hydrocephalus and symptoms of raised intracranial pressure. Ventricular shunting in such cases permits a sudden increase in CBF. The pathophysiology of functional brain deficit secondary to hydrocephalus is little understood. Improvement of the patient's clinical status after drainage of CSF suggests that cerebral dysfunction is not necessarily due to permanent brain damage. In fact, it improves rapidly after ventricular taps. In view of this it would be helpful to monitor cerebral perfusion. The transcranial Doppler (TCD) ultrasonography technique allows real-time monitoring of the intracranial circulation…

MaleIntracranial PressureUltrasonography Doppler TranscranialVentriculoperitoneal ShuntPostoperative ComplicationsCerebrospinal Fluid PressureMonitoring Intraoperativemedicine.arterymedicineHumansCerebral perfusion pressureChildTranscranial doppler Hydrocephalus pediatric patientsbusiness.industrySettore MED/27 - NeurochirurgiaBrainInfantGeneral Medicinemedicine.diseaseHydrocephalusTranscranial DopplerShuntingmedicine.anatomical_structureCerebral blood flowVentricleAnesthesiaPediatrics Perinatology and Child HealthMiddle cerebral arteryCerebral ventriclecardiovascular systemFemaleNeurology (clinical)businessBlood Flow VelocityHydrocephalus
researchProduct

Long-Term Follow-Up of Repeat Endoscopic Third Ventriculostomy in Obstructive Hydrocephalus.

2017

Endoscopic third ventriculostomy (ETV) is a safe and less-invasive treatment strategy for patients with obstructive hydrocephalus and provides excellent outcome. Nevertheless, repeat ETV in cases of ETV failure is a controversial issue.Between 1993 and 1999, 113 patients underwent a total of 126 ETVs at the Department of Neurosurgery, Mainz University Hospital. Obstructive hydrocephalus was the causative pathology in all cases. A very long-term follow-up of up to 16 years could be achieved. All medical reports of patients who received ETV were reviewed and analyzed with focus on ETV failure with following repeat ETV and its initial as well as very long-term success.Thirty-one events of ETV …

MaleReoperationmedicine.medical_specialtyPediatricsAdolescentLong term follow upObstructive hydrocephalusConstriction PathologicVentriculostomyCentral Nervous System Neoplasms03 medical and health sciencesYoung Adult0302 clinical medicinemedicineHumansTreatment FailureChildRetrospective StudiesThird Ventriclebusiness.industryCystsEndoscopic third ventriculostomyCerebral AqueductInfantUniversity hospitalSurgeryTreatment Outcome030220 oncology & carcinogenesisChild PreschoolNeuroendoscopyCerebrospinal fluid circulationTreatment strategySurgeryFemaleNeurology (clinical)NeurosurgerybusinessIntracranial Hemorrhages030217 neurology & neurosurgeryFollow-Up StudiesHydrocephalusWorld neurosurgery
researchProduct

A survey on current practice in the neurosurgical management of preterm infants with posthemorrhagic hydrocephalus in Germany.

2012

Background and Study Aims  Different approaches to the management of preterm infants with posthemorrhagic hydrocephalus (PHH) are described in the literature. Likewise, neurosurgical and pediatric surgical departments in German hospitals use different methods to treat these patients. The aim of this study was therefore to assess the current situation regarding the management of PHH, which is a first and essential step toward the development of standards of practice. Patients and Methods  In the second half of 2009, we sent standardized questionnaires to 139 neurosurgical departments (number of returned questionnaires: 98) and 73 pediatric surgical departments (returned questionnaires: 62) t…

medicine.medical_specialtyPediatricsNeurosurgeryPediatricsVentriculoperitoneal ShuntNeurosurgical ProceduresVentriculoperitoneal shuntsPosthemorrhagic hydrocephalusGermanySurveys and QuestionnairesPediatric surgeryMedicineInitial treatmentHumansPractice Patterns Physicians'Csf shuntbusiness.industryData CollectionInfant Newbornmedicine.diseasehumanitiesIntraventricular hemorrhageCurrent practicePractice Guidelines as TopicSurgeryNeurology (clinical)NeurosurgerybusinessIntracranial HemorrhagesInfant PrematureHydrocephalusJournal of neurological surgery. Part A, Central European neurosurgery
researchProduct

Letter: Cerebrospinal Fluid Shunting Improves Long-Term Quality of Life in Idiopathic Normal Pressure Hydrocephalus.

2020

medicine.medical_specialtybusiness.industryCerebrospinal Fluid ShuntsHydrocephalus Normal PressureNeurosurgical ProceduresTerm (time)ShuntingCerebrospinal fluidQuality of lifeInternal medicine(Idiopathic) normal pressure hydrocephalusmedicineCardiologyQuality of LifeHumansSurgeryNeurology (clinical)businessVascular Surgical ProceduresCerebrospinal Fluid Shunts Hydrocephalus Humans Neurosurgical Procedures Vascular Surgical Procedures Quality of Life Hydrocephalus Normal PressureHydrocephalusNeurosurgery
researchProduct

Cognitive, biochemical, and imaging profile of patients suffering from idiopathic normal pressure hydrocephalus

2011

Abstract Introduction It has still not been clearly established whether the cognitive deficits of idiopathic normal pressure hydrocephalus (iNPH) are caused by a disturbance in cerebrospinal fluid (CSF) dynamics or an underlying metabolic disturbance. Objective To identify the possible associations between biochemical markers, the neuroimaging characteristics, and cognitive deficits of patients undergoing investigations for possible iNPH. Methods A CSF sample obtained during a lumbar puncture from 10 patients with iNPH was analyzed for several biochemical markers (lactate, 8-isoprostane, vascular endothelial growth factor [VEGF], neurofilament heavy protein, glial fibrillary acidic protein,…

Malemedicine.medical_specialtyPathologyEpidemiologyNerve Tissue ProteinsNeuroimagingCerebral VentriclesWhite matterCellular and Molecular NeuroscienceCerebrospinal fluidDevelopmental NeuroscienceNormal pressure hydrocephalusInternal medicinemedicineHumansProspective StudiesCognitive deficitAgedAged 80 and overmedicine.diagnostic_testGlial fibrillary acidic proteinbiologyLumbar punctureHealth PolicyBrainhydrocefalusMiddle Agedmedicine.diseaseHydrocephalus Normal PressureHydrocephalusPsychiatry and Mental healthmedicine.anatomical_structurebiology.proteinCardiologyFemaleNeurology (clinical)Geriatrics and Gerontologymedicine.symptomCognition DisordersPsychologyVentriculomegalyAlzheimers & Dementia
researchProduct

Peripheral facial palsy following ventriculoperitoneal shunt. The lesson we have learned

2018

The most frequent complications after shunt surgery are infective and obstructive. Other types are less common, and eventually occur due to technical errors during brain ventricular puncture, opening the intraperitoneal cavity or the tunnelling of the catheter between the two points. Although rare, there are well-reported complications related to the poor positioning of the distal catheter, with perforation of organs and tissues.We report a very rare case of a male patient with normal pressure hydrocephalus submitted to ventriculoperitoneal shunt. During tunnelling of the shunt stylet, a peripheral facial palsy due to injury to the extra cranial segment of the facial nerve occurred.To the b…

medicine.medical_specialtylcsh:SurgeryFacial nerve paralysis Normal pressure hydrocephalus Ventriculoperitoneal shunt complicationslcsh:RC346-42903 medical and health sciences0302 clinical medicineNormal pressure hydrocephalusmedicinelcsh:Neurology. Diseases of the nervous systemMastoid regionPeripheral facial palsybusiness.industrySettore MED/27 - Neurochirurgialcsh:RD1-811medicine.diseaseFacial nerveSurgeryStyletShunt (medical)Catheter030220 oncology & carcinogenesisSurgeryNeurology (clinical)Complicationbusiness030217 neurology & neurosurgery
researchProduct

The Role of Third Ventriculostomy in the Management of Obstructive Hydrocephalus

2003

Objective: Endoscopic third ventriculostomy (ETV) is an effective treatment for occlusive hydrocephalus caused by an obstruction of the CSF flow in the aqueduct or the posterior fossa. We evaluated the factors age, pathology and surgical technique on the results of the ETV. Methods: Between November 1992 and October 2000 171 ETV have been performed in 159 patients. The follow-up was evaluated in 150 patients. The age ranged from 10 days to 77 years (mean age 35 years). The hydrocephalus was caused by benign aqueductal stenosis in 77 patients, space-occupying lesions in 59, by intraventricular hemorrhages in 11, and by other causes in 3 patients. The trajectory was planned in 31 patients by …

AdultMaleVentriculostomymedicine.medical_specialtyAdolescentmedicine.medical_treatmentObstructive hydrocephalusVentriculostomyStereotaxic TechniquesCentral nervous system diseasePostoperative ComplicationsOutcome Assessment Health CaremedicineHumansChildAgedThird Ventriclemedicine.diagnostic_testbusiness.industryAge FactorsInfant NewbornEndoscopic third ventriculostomyInfantEndoscopyGeneral MedicineMiddle Agedmedicine.diseaseSurgeryHydrocephalusEndoscopyHemiparesisAqueductal stenosisChild PreschoolFemaleSurgeryNeurology (clinical)medicine.symptombusinessFollow-Up StudiesHydrocephalusmin - Minimally Invasive Neurosurgery
researchProduct

Cerebrospinal Fluid Dynamics Following Ventriculoperitoneal Shunt in Hydrocephalus: Do Technological Advancements Avoid Complications?

2022

General NeuroscienceHumansGeneral MedicineVentriculoperitoneal Shunt Hydrocephalus complicationsVentriculoperitoneal ShuntHydrocephalusJournal of integrative neuroscience
researchProduct

A Rare Case of Docetaxel-Induced Hydrocephalus Presenting with Gait Disturbances Mimicking and Coexisting with Taxane-Associated Polyneuropathy: The …

2017

Docetaxel constitutes a widely used chemotherapeutic agent as a first-line treatment for several neoplastic diseases. One of the most common side effects induced by this drug is polyneuropathy, which among other symptoms can cause gait disbalance. However, in exceptional cases gait disturbances could be related to docetaxel-induced hydrocephalus, a rare event that up to the present has been overseen throughout the medical literature and should be meticulously differentiated from polyneuropathy, since its clinical features, treatment, and prognosis differ drastically. We present the case of a woman with a progressive gait disturbance that started immediately after having been treated with do…

Gait disturbancesmedicine.medical_specialtyCase ReportDocetaxelVentricular systemlcsh:RC254-28203 medical and health sciences0302 clinical medicineBreast cancerNormal pressure hydrocephalusPolyneuropathyMedicinebusiness.industryGait Disturbancelcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseHydrocephalusSurgeryOncologyDocetaxel030220 oncology & carcinogenesisDifferential diagnosisbusinessPolyneuropathy030217 neurology & neurosurgeryHydrocephalusmedicine.drugCase Reports in Oncology
researchProduct